If you’re reading this, you’re probably considering outsourced lateral flow manufacturing and fall into one of these categories?
In-house manufacturing may be an activity that is non-core to your main operations. Because of this it may take up significant revenue or space that could be better utilised. This opportunity-cost is often overlooked.
Increasing your in-house manufacturing capacity through investment in new capital equipment is expensive and may not be the best use of this capital. Your current process may not be efficient and may be impacting your profit margins.
Waiting for your current partner to increase capacity and/or resources in order to meet demand or reach new territories will also take time, and possibly squander growth opportunities. In addition, this exercise is probably out of your control.
Control of your own destiny is important so the first step needs to be switching to a lateral flow manufacturer with capabilities, resources and expertise already in place. Don’t be discouraged about having to do this, a good manufacturer can manage this under an established change control process in a time and cost-efficient manner.
Working with a well-established partner with a breadth of lateral flow manufacturing, regulatory and commercial expertise means you don’t have to consider Capital Expenditure, additional in-house manufacturing labour costs, or miss growth or profit opportunities. Therefore, whether you need to move away from in-house manufacturing or change partner, focus can remain on meeting your business’ and customers’ needs.
Helping companies deliver robust rapid tests to market is something Abingdon Health is very proud of. If you would like to investigate outsourcing options with a partner who is more than just a lateral flow manufacturer, please contact Abingdon Health.